| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 21 Mar 2025 | 21 Mar 2025 |
| Outcome of Board Meeting held on March 21, 2025 | ||
| Board Meeting | 12 Feb 2025 | 3 Feb 2025 |
| Entero Healthcare Solutions Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2025 inter alia to consider and approve and take on record the standalone and consolidated unaudited financial results of the Company for the Quarter and Nine-months ended December 31 2024. Submission of Unaudited Financial Results for the quarter and nine months ended December 31, 2024 Outcome of Board Meeting held on February 12, 2025 (As Per BSE Announcement Dated on 12/02/2025) | ||
| Board Meeting | 16 Jan 2025 | 16 Jan 2025 |
| Intimation for appointment of Mrs. Sanu Vishal Kapoor as Company Secretary and Compliance Officer of the Company. Allotment of equity shares against the exercise of ESOPs | ||
| Board Meeting | 12 Nov 2024 | 6 Nov 2024 |
| Entero Healthcare Solutions Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2024 inter alia to consider and approve the standalone and consolidated unaudited financial results of the Company for the quarter and half year ended September 30 2024. Outcome of Board Meeting held on November 12, 2024 (As Per Bse Announcement Dated on 12.11.2024) | ||
| Board Meeting | 14 Aug 2024 | 8 Aug 2024 |
| Entero Healthcare Solutions Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2024 inter alia to consider and approve Unaudited Financial Results for the quarter ended June 30 2024 Outcome of Board Meeting held on August 14, 2024 (As per BSE Announcement Dated on 14/08/2024) | ||
| Board Meeting | 2 Aug 2024 | 2 Aug 2024 |
| Submission of outcome of Board Meeting held on August 02, 2024 | ||
| Board Meeting | 28 Jun 2024 | 28 Jun 2024 |
| Outcome of Board Meeting held on June 28, 2024 Entero Healthcare Solutions Limited (Entero) has informed the Exchange about acquisition of Devi Pharma Wellness Private Limited approved by the Board of Entero at its meeting held on June 28, 2024. | ||
| Board Meeting | 29 May 2024 | 22 May 2024 |
| Entero Healthcare Solutions Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2024 inter alia to consider and approve Audited Financial Results of the Company for the quarter and year ended March 31 2024 Audited Standalone & Consolidated Financial Results for the Quarter and Year ended March 31, 2024 Outcome of Board Meeting held on May 29, 2024 (As Per BSE Announcement Dated on 29.05.2024) Revised outcome due type error in Annexure E (As Per BSE Announcement Dated on 30.05.2024) | ||
| Board Meeting | 6 May 2024 | 6 May 2024 |
| The Board of Directors of Entero Healthcare Solutions Limited (Company) has approved, inter-alia, to execute the definitive agreements to acquire 80% paid-up equity share capital of Avenir Lifecare Pharma Private Limited (ALPPL) at their meeting held today i.e. 6th May 2024. The Board of Directors of Entero Healthcare Solutions Limited (Company) has approved, inter-alia, to execute the definitive agreement to acquire 80% paid up equity capital share capital of Avenir Lifecare Pharma Private Limited (ALPPL) at their meeting held on May 06, 2024. | ||
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
